| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $21,719,984 ) (Continued on the next page) |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 001 | 3 | NIH | 3/27/2026 | $83,224 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 001 | 5 | NIH | 2/25/2026 | $58,897 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 001 | 3 | NIH | 2/25/2026 | $59,818 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI183676 | Defining the Regulatory Landscape of Lupus with CVD Comorbidity | 000 | 2 | NIH | 11/26/2025 | $847,133 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DA060226 | Effects of tobacco smoking on prognosis and immune function in multiple sclerosis | 000 | 2 | NIH | 2/18/2026 | $552,147 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG099844 | Dissecting Inflammatory and Immune Mechanisms Driving Ovarian Tissue Aging | 001 | 1 | NIH | 3/16/2026 | $48,231 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 000 | 2 | NIH | 12/10/2025 | $135,057 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 000 | 3 | NIH | 12/16/2025 | $383,625 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R03DE034789 | PDGFRbeta-mediated skeletal-vascular crosstalk in calvarial bone marrow development | 000 | 1 | NIH | 2/13/2026 | $341,000 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DA062881 | Cell type-specific neurotensin signaling in methamphetamine use disorder | 000 | 1 | NIH | 2/6/2026 | $648,389 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 001 | 4 | NIH | 5/14/2026 | $26,479 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY034946 | Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet | 000 | 3 | NIH | 1/29/2026 | $531,146 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 000 | 5 | NIH | 1/28/2026 | $530,077 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 000 | 3 | NIH | 1/26/2026 | $538,367 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 000 | 2 | NIH | 1/23/2026 | $538,719 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 000 | 4 | NIH | 1/27/2026 | $457,898 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI168355 | Complement C5 inhibition as sepsis therapy | 000 | 5 | NIH | 1/26/2026 | $633,416 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 000 | 4 | NIH | 1/30/2026 | $507,628 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG077812 | A novel role for oxidized lipid mediators as effectors of muscle atrophy and weakness in aging | 000 | 5 | NIH | 5/18/2026 | $534,035 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21EY037427 | Mechanistic investigations of tryptophan catabolites for vision improvement in Multiple Sclerosis | 000 | 1 | NIH | 4/17/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 001 | 4 | NIH | 4/16/2026 | $50,879 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 002 | 3 | NIH | 3/31/2026 | $1,356 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DK085691 | Colon O-glycosylated mucus in the homeostasis of microbiota and host | 000 | 13 | NIH | 4/8/2026 | $731,770 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AI176244 | Autoimmune Drivers and Protectors Team Science (ADAPTS) | 000 | 4 | NIH | 5/7/2026 | $1,288,071 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 001 | 4 | NIH | 3/13/2026 | $16,029 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM137921 | Mechanisms of mitochondrial subpopulation formation and maintenance | 001 | 6 | NIH | 3/13/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY033782 | Interrogating the intersection between diet and ocular autoimmunity | 000 | 5 | NIH | 4/13/2026 | $541,165 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 001 | 3 | NIH | 3/20/2026 | $42,625 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 000 | 4 | NIH | 4/10/2026 | $426,250 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 001 | 4 | NIH | 3/24/2026 | $32,699 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 001 | 2 | NIH | 3/25/2026 | $59,856 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM160259 | Regulation of gene transcription and DNA replication by chromatin readers from the BET family | 000 | 2 | NIH | 5/5/2026 | $468,875 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 5 | NIH | 4/27/2026 | $941,759 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 5 | NIH | 4/27/2026 | $196,992 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 5 | NIH | 4/27/2026 | $100,000 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 5 | NIH | 4/27/2026 | $5,211,248 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 5 | NIH | 4/27/2026 | $1,000,000 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG099844 | Dissecting Inflammatory and Immune Mechanisms Driving Ovarian Tissue Aging | 002 | 1 | NIH | 4/21/2026 | $0 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG099844 | Dissecting Inflammatory and Immune Mechanisms Driving Ovarian Tissue Aging | 000 | 1 | NIH | 3/6/2026 | $663,248 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 000 | 4 | NIH | 3/6/2026 | $621,316 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 000 | 4 | NIH | 1/22/2026 | $476,629 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AG093578 | Cell-type specific role of melanocortin 4 receptor in inflammation and cognition with aging | 001 | 2 | NIH | 3/9/2026 | $253,666 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 001 | 2 | NIH | 2/24/2026 | $0 |
| | 2026 | 2026 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 000 | 4 | NIH | 2/27/2026 | $366,575 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI156724 | Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE | 000 | 5 | NIH | 2/17/2026 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 000 | 5 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | P20GM139763 | Center for Cellular Metabolism Research in Oklahoma | 001 | 5 | NIH | 12/5/2025 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL145237 | Translational Control of Megakaryocyte and Platelet Gene Expression in Disease | 000 | 7 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AI194204 | Notch regulation of airway epithelial-immune cell cross-talk in SARS-CoV-2 infection | 000 | 1 | NIH | 2/6/2026 | $0 |
|
